
Location: France
Total raised: $7M
Funding Rounds 1
Date | Series | Amount | Investors |
03.09.2025 | Seed | $7M | Plug and P... |
Mentions in press and media 5
Date | Title | Description |
04.09.2025 | ArcaScience Secures $7M to Revolutionize Drug Evaluation with AI | ArcaScience secured $7M seed funding. This investment propels AI-driven drug benefit-risk evaluation. The company will expand US and UK operations, launching crucial patient solutions. Focus areas include pediatric brain cancer and dermatol... |
03.09.2025 | ArcaScience raises $7M to expand AI benefit risk platform in drug development Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies | French artificial intelligence healthtech startup ArcaScience SAS revealed today that it has raised $7 million in new funding to expand into the U.S. and the U.K., launch a patient-facing solution for pediatric brain cancer and dermatologic... |
03.09.2025 | ArcaScience raises $7M to transform drug development with AI-driven insights | AI healthtech startup ArcaScience has raised $7 million in seed funding to expand in the US and UK, launch patient solutions, and advance safer drug evaluation. The round was led by The Moon Venture, with participation from Pléiade Venture,... |
03.09.2025 | ArcaScience Raises $7M to Advance AI-Powered Drug Benefit-Risk Evaluation | What You Should Know: – ArcaScience, a Paris, France-based AI Healthtech startup, has announced a $7M seed funding round led by The Moon Venture, with participation from Pléiade Venture, Plug&Play Ventures, Bpifrance, and AKKA Technolog... |
- | ArcaScience | “ArcaScience - Seek less, discover better” |